These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34792142)

  • 1. Pharmacodynamic/pharmacokinetic correlation of optimized ibuprofen nanosuspensions having enhanced anti-inflammatory and antinociceptive activity.
    Bandarkar F; Masocha W; Nada A
    J Pharm Pharmacol; 2022 Mar; 74(3):387-396. PubMed ID: 34792142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo Evaluation of Ibuprofen Nanosuspensions for Enhanced Oral Bioavailability.
    Hedaya M; Bandarkar F; Nada A
    Med Princ Pract; 2021; 30(4):361-368. PubMed ID: 33823524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging the Gap Between In Vitro Dissolution and the Time Course of Ibuprofen-Mediating Pain Relief.
    Cristofoletti R; Dressman JB
    J Pharm Sci; 2016 Dec; 105(12):3658-3667. PubMed ID: 27751586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
    Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the Interaction between Diclofenac and Ibuprofen with Benzalkonium Chloride to Prepare Ocular Nanosuspension.
    Tak D; Rimpy ; Kumar T; Ahuja M
    Recent Pat Drug Deliv Formul; 2019; 13(4):301-309. PubMed ID: 31849291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
    Pignatello R; Bucolo C; Ferrara P; Maltese A; Puleo A; Puglisi G
    Eur J Pharm Sci; 2002 Jul; 16(1-2):53-61. PubMed ID: 12113891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing disintegration and dissolution rates, pharmacokinetic profiles and gastrointestinal tolerability of over the counter ibuprofen formulations.
    Bjarnason I; Sancak O; Crossley A; Penrose A; Lanas A
    J Pharm Pharmacol; 2018 Feb; 70(2):223-233. PubMed ID: 29238984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique.
    Li DX; Oh YK; Lim SJ; Kim JO; Yang HJ; Sung JH; Yong CS; Choi HG
    Int J Pharm; 2008 May; 355(1-2):277-84. PubMed ID: 18243606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel drug-drug salt crystals of metformin with ibuprofen or naproxen: Improved solubility, dissolution rate, and synergistic antinociceptive effects.
    Qin HM; Luo ZK; Zhou HL; Zhu J; Xiao XY; Xiao Y; Zhuang T; Zhang GS
    Int J Pharm; 2024 May; 657():124126. PubMed ID: 38626845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
    Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
    Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen.
    Trocóniz IF; Armenteros S; Planelles MV; Benítez J; Calvo R; Domínguez R
    Clin Pharmacokinet; 2000 Jun; 38(6):505-18. PubMed ID: 10885587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.
    Lamprecht A; Saumet JL; Roux J; Benoit JP
    Int J Pharm; 2004 Jul; 278(2):407-14. PubMed ID: 15196644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration.
    Rhee YS; Chang SY; Park CW; Chi SC; Park ES
    Int J Pharm; 2008 Nov; 364(1):14-20. PubMed ID: 18755258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration.
    Suri A; Grundy BL; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):1-8. PubMed ID: 9021434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of crystalline sodium salt and polymeric precipitation inhibitors to improve pharmacokinetic profile of ibuprofen through supersaturation.
    Terebetski JL; Cummings JJ; Fauty SE; Michniak-Kohn B
    AAPS PharmSciTech; 2014 Oct; 15(5):1334-44. PubMed ID: 24920524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
    Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
    Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability study of two oral formulations of ibuprofen.
    Corpetti G; Rosignoli MT; Dionisio P
    Arzneimittelforschung; 1998 Apr; 48(4):392-5. PubMed ID: 9608882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antinociceptive activity of nanoliposome-encapsulated and free-form diclofenac in rats and mice.
    Goh JZ; Tang SN; Chiong HS; Yong YK; Zuraini A; Hakim MN
    Int J Nanomedicine; 2015; 10():297-303. PubMed ID: 25678786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.